We are live on ! Find out more
BC

Blackhill Capital Portfolio holdings

AUM $1.94B
1-Year Est. Return 18.09%
This Fund
S&P 500
This Quarter Est. Return
+12.13%
1 Year Est. Return
+18.09%
3 Year Est. Return
+164.47%
5 Year Est. Return
+136.25%
10 Year Est. Return
+688.12%
AUM
$829M
AUM Growth
+$89.4M
Cap. Flow
+$6.36M
Cap. Flow %
0.77%
Top 10 Hldgs %
82.19%
Holding
59
New
3
Increased
8
Reduced
8
Closed
1

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$3.59M
2
ELAN icon
Elanco Animal Health
ELAN
+$3.26M
3
WSM icon
Williams-Sonoma
WSM
+$894K
4
VTRS icon
Viatris
VTRS
+$800K
5
KRON
Kronos Bio
KRON
+$267K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$981K
2
PFE icon
Pfizer
PFE
+$791K
3
PM icon
Philip Morris
PM
+$389K
4
ZBH icon
Zimmer Biomet
ZBH
+$196K
5
ZTS icon
Zoetis
ZTS
+$97.6K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 49.99%
2 Healthcare 32.03%
3 Technology 6.33%
4 Communication Services 4.6%
5 Consumer Staples 2.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NKE icon
51
Nike
NKE
$61.3B
$198K 0.02%
1,400
– –
MDY icon
52
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
$147K 0.02%
351
– –
HSY icon
53
Hershey
HSY
$36.6B
$91K 0.01%
600
– –
NSC icon
54
Norfolk Southern
NSC
$75.2B
$48K 0.01%
200
– –
TR icon
55
Tootsie Roll Industries
TR
$2.97B
$33K ﹤0.01%
1,318
– –
ED icon
56
Consolidated Edison
ED
$39.8B
$18K ﹤0.01%
253
– –
META icon
57
Meta Platforms (Facebook)
META
$1.53T
$8K ﹤0.01%
+31
New +$8.5K
BMY.RT
58
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
– –
-28,000
Closed -$63K
1 2
3

Similar funds

FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
OCM
Osterweis Capital Management San Francisco, California $1.94B AUM 20.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Blackhill Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Blackhill Capital held 59 positions worth $829M, up 12% from $740M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Blackhill Capital's Q4 2020 filing shows 3 new, 8 increased, 8 reduced and 1 closed positions. Its largest new stake was Viatris: 49,052 shares worth $919K. The largest sale was Eli Lilly, an estimated $981K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 50% of assets, up from 50% a quarter earlier, followed by Healthcare and Technology.

  • Blackhill Capital's largest Q4 2020 buy was Viatris: 49,052 shares worth $919K.
  • Blackhill Capital added most to Merck in Q4 2020, an estimated $3.59M increase.
  • Blackhill Capital's biggest Q4 2020 reduction was Eli Lilly, cutting an estimated $981K.
  • Blackhill Capital fully exited Bristol-Myers Squibb Company Contingent Value Rights in Q4 2020, selling an estimated $63K.
  • Blackhill Capital's ten largest holdings make up 82% of its $829M portfolio in Q4 2020.
  • Blackhill Capital opened 3 new positions and closed 1 in Q4 2020.
  • Blackhill Capital's portfolio value rose 12% quarter-over-quarter to $829M.

Based on Blackhill Capital's 13F filing for Q4 2020, filed 8 Feb 2021.